Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study
2020 ◽
Vol 82
(2)
◽
pp. 389-397
◽
Amy S. Paller
◽
Ying Hong
◽
Emily M. Becker
◽
Raul de Lucas
◽
Maria Paris
◽
...
2019 ◽
Vol 81
(4)
◽
pp. AB120
Maureen M. O'Brien
◽
Todd A. Alonzo
◽
Todd M. Cooper
◽
John E. Levine
◽
Patrick A. Brown
◽
...
2004 ◽
Vol 50
(3)
◽
pp. P2
◽
Alan Menter
◽
Deborah Lew-Kaya
◽
Frederick Beddingfield
◽
Patricia S. Walker
2020 ◽
Vol 4
(5)
◽
pp. s38
Mark G Lebwohl
◽
Jeffrey Sugarman
◽
David M Pariser
◽
Jerry Bagel
◽
Cynthia Trickett
◽
...
2011 ◽
Vol 23
(4)
◽
pp. 255-260
◽
Gino A. Vena
◽
Antonia Galluccio
◽
Michele Pezza
◽
Michelangelo Vestita
◽
Nicoletta Cassano
2017 ◽
Vol 177
(2)
◽
pp. 411-418
◽
J. Bagel
◽
S. Tyring
◽
K.C. Rice
◽
D.H. Collier
◽
G. Kricorian
◽
...
M.G. Lebwohl
◽
L. Stein Gold
◽
K. Papp
◽
G. Han
◽
D.M. Pariser
◽
...
2019 ◽
Vol 80
(1)
◽
pp. 282-285
◽
Mark G. Lebwohl
◽
Jeffrey L. Sugarman
◽
Linda Stein Gold
◽
David M. Pariser
◽
Tina Lin
◽
...
2021 ◽
Vol 85
(3)
◽
pp. AB66
Vivian Laquer
◽
David Davidson
◽
Andrea Nguyen
◽
Tien Nguyen